AzTrials
AzTrials

White Spot LesionNCT07319884

The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled Split-Mouth Study

A study testing White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application in people with White Spot Lesion, run by Mansoura University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control… Read more about this study

Who is it for?
Ages 16 to 24 yearsHealthy volunteers can take part
Conditions the study is for
White Spot Lesion
What is being tested?
White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteEgypt
Study dates
25 Jun 2025to 1 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 24 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • patients aged 16-24 years.
  • Good general and oral health.
  • Mild dental crowding per arch (≤ 4 mm).
  • Eruption of all permanent dention excluding third molar

Who cannot join

  • Allergy to fluoride material
  • Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
  • Patients with Cleft lip and palate
  • Previous orthodontic treatment
  • dental fluorosis.
  • hypocalcified teeth or visible demineralization

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of dentistry Mansoura University

    Al Mansurah

Other trials in Egypt

About this study

aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy

Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control without fluoride varnish.

Outcomes:

Primary outcome: Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)

Secondary Outcome:

Periodontal Ligament (PDL) Health using pocket Depth Index (PDI) Gingival Bleeding and Inflammation using bleeding on Probing Index (BOP)

Read the detailed description

aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy in comparison to a split mouth-controlled group

Sample size calculation:

The sample size was calculated using G* power software (version3.1.9.7) and was designed to have a power of 85% assuming a type I statistical error of 5% and a one tailed statistical test with an effect size f= 0.7730012 based on the study of Najafi et al. The means and standard deviation of the DIAGNOdent score of the varnish and control groups after six months were 1.23 ±0.45 and 1.78±0.90. The calculated sample size will be 25 patients. The sample size will be increased to include 30 patients to avoid any drop out.

Material and methods:

  1. Initial Oral Scan:
  • A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner
  1. Aligner Fabrication:
  • aligners will be fabricated using thermoforming techniques.
  • A clear aligner sheet (e.g.Duran) is heated and vacuum or pressure-formed over the 3D-printed model, then trimming followed by finishing and polishing
  1. Interventions

Intervention Group (Test Side):

  • Application of a preventive fluoride varnish (Charm varnish) on the indicated side of the mouth before clear aligner fitting.

Control Group (Control Side):

  • Without application of fluoride varnish 4. Aligner Placement:
  • The aligners will be fitted, and patients will wear them continuously, except during eating and brushing.

Outcome Measures:

Primary Outcome:

  • Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)

Secondary Outcome:

  1. Periodontal Ligament (PDL) Health using:
  • Pocket Depth Index (PDI)
  1. Gingival Bleeding and Inflammation using:
  • Bleeding on Probing Index (BOP)

Randomization and Application Site

To minimize bias, the side of the maxillary arch (right or left upper side) for fluoride varnish application was randomly assigned for each of the patients using a computer-generated randomization sequence

Inclusion and Exclusion Criteria Eligible participants were patients aged 16-24 years, representing the typical demographic for clear aligner therapy and ensuring biological consistency in terms of tooth development and orthodontic response. All participants were required to be in good general and oral health to minimize confounding factors related to systemic or oral disease, to present with mild dental crowding in each arch to standardize treatment complexity, and to have full eruption of all permanent teeth excluding third molars to allow consistent varnish application and assessment. Patients were excluded if they had a known allergy or hypersensitivity to fluoride-containing materials, systemic conditions that could affect tooth movement (such as diabetes or bone metabolism disorders), cleft lip and/or palate or other craniofacial anomalies, a history of previous orthodontic treatment, or clinical evidence of dental fluorosis, as these factors could alter enamel characteristics, orthodontic response, or lesion assessment and thereby introduce bias into the study outcomes.

Duration of the study:

  • This study is suggested to be finished in 18 months
Being tested
White spot lesion with fluoride varnish application, White spot lesion without fluoride varnish application

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • White spot lesion with fluoride varnish applicationOther

    Application of fluoride varnish at the cervical third of labial surface or around the attachment if present

  • White spot lesion without fluoride varnish applicationOther

    No fluoride varnish application at the cervical third of the labial surface or around the attachment if present

Study groups in NCT07319884
Study groupRoleWhat they receive
White spot lesion with fluoride varnish application during clear Aligner therapyExperimentalIntervention Group (Test Side): • Application of a preventive fluoride varnish on the indicated side of the mouth before clear aligner fitting.
Receives: Other: White spot lesion with fluoride varnish application
White spot lesion without fluoride varnish application during clear Aligner therapyActive comparatorControl Group (Control Side): No application of fluoride varnish.
Receives: Other: White spot lesion without fluoride varnish application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence and Severity of White Spot Lesions

    Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)

    Measured: Six months

Secondary outcomes (2)
  1. Periodontal Ligament (PDL) Health

    Health using pocket Depth Index (PDI)

    Measured: Six moths

  2. Gingival Bleeding and Inflammation

    using bleeding on Probing Index (BOP)

    Measured: Six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2026
  2. Study start25 Jun 2025
  3. Primary completion25 Jan 2027 (estimated)
  4. Study completion1 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07319884
Sponsor's protocol ID
Mansoura-university
Status last verified
Dec 2025
First submitted
20 Dec 2025
Last updated
6 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application in people with White Spot Lesion, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence and Severity of White Spot Lesions (time frame: Six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in